These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38073340)

  • 1. Effect of hydration therapy and nursing intervention on preventing contrast-induced nephropathy after interventional treatment of lower extremity arteriosclerosis obliterans.
    Chen J; Zhang X; Wu W; Yuan Y; Xue W; Cao W; Du R
    Technol Health Care; 2024; 32(3):1361-1369. PubMed ID: 38073340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effects of different hydration strategies before endovascular treatments to the renal function of the arteriosclerosis obliterans patients].
    Zhu YT; Xiong J; Guo W; Liu XP; Yin T; Jia X; Ma XH; DU X
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(17):1155-8. PubMed ID: 20646558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of probucol combined with hydration in preventing contrast-induced nephropathy in patients with coronary heart disease undergoing percutaneous coronary intervention: a multicenter, prospective, randomized controlled study.
    Fu N; Yang S; Zhang J; Zhang P; Liang M; Cong H; Lin W; Tian F; Lu C
    Int Urol Nephrol; 2018 Jan; 50(1):105-112. PubMed ID: 29071556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Febuxostat combined with hydration for the prevention of contrast-induced nephropathy in hyperuricemia patients undergoing percutaneous coronary intervention: A CONSORT-compliant randomized controlled trial.
    Ma G; Li M; Teng W; He Z; Zhai X; Xia Z
    Medicine (Baltimore); 2022 Jan; 101(4):e28683. PubMed ID: 35089218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial].
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; van Ommen V; Wildberger JE
    Ned Tijdschr Geneeskd; 2018; 161():D1734. PubMed ID: 29328007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial.
    Marenzi G; Ferrari C; Marana I; Assanelli E; De Metrio M; Teruzzi G; Veglia F; Fabbiocchi F; Montorsi P; Bartorelli AL
    JACC Cardiovasc Interv; 2012 Jan; 5(1):90-7. PubMed ID: 22230154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial.
    Kong DG; Hou YF; Ma LL; Yao DK; Wang LX
    Acta Cardiol; 2012 Oct; 67(5):565-9. PubMed ID: 23252007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a rehabilitation management strategy based on symptom management theory in postoperative functional exercises in patients with lower extremity arteriosclerosis obliterans.
    Yuan Y; Chen J; Wang X; Song J
    Technol Health Care; 2024; 32(1):63-73. PubMed ID: 37248923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydration with sodium bicarbonate does not prevent contrast nephropathy: a multicenter clinical trial.
    Gomes VO; Lasevitch R; Lima VC; Brito FS; Perez-Alva JC; Moulin B; Arruda A; Oliveira D; Caramori P
    Arq Bras Cardiol; 2012 Dec; 99(6):1129-34. PubMed ID: 23184077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of hydration in contrast-induced nephropathy in patients who underwent primary percutaneous coronary intervention.
    Jurado-Román A; Hernández-Hernández F; García-Tejada J; Granda-Nistal C; Molina J; Velázquez M; Albarrán A; Tascón J
    Am J Cardiol; 2015 May; 115(9):1174-8. PubMed ID: 25759106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of hydration with or without n-acetylcysteine on contrast induced nephropathy in patients undergoing coronary angiography and percutaneous coronary intervention.
    Awal A; Ahsan SA; Siddique MA; Banerjee S; Hasan MI; Zaman SM; Arzu J; Subedi B
    Mymensingh Med J; 2011 Apr; 20(2):264-9. PubMed ID: 21522098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial.
    Nijssen EC; Rennenberg RJ; Nelemans PJ; Essers BA; Janssen MM; Vermeeren MA; Ommen VV; Wildberger JE
    Lancet; 2017 Apr; 389(10076):1312-1322. PubMed ID: 28233565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Safety Guidelines on the Use of Iodinated Contrast Material: Conundrum Continued.
    Nijssen EC; Nelemans PJ; Rennenberg RJ; van Ommen V; Wildberger JE
    Invest Radiol; 2018 Oct; 53(10):616-622. PubMed ID: 29762257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS--a multicenter prospective controlled trial.
    Koc F; Ozdemir K; Kaya MG; Dogdu O; Vatankulu MA; Ayhan S; Erkorkmaz U; Sonmez O; Aygul MU; Kalay N; Kayrak M; Karabag T; Alihanoglu Y; Gunebakmaz O
    Int J Cardiol; 2012 Mar; 155(3):418-23. PubMed ID: 21106264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
    Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
    Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is treatment with N-acetylcysteine to prevent contrast-induced nephropathy when using bicarbonate hydration out of date?
    Heng AE; Cellarier E; Aublet-Cuvelier B; Decalf V; Motreff P; Marcaggi X; Deteix P; Souweine B
    Clin Nephrol; 2008 Dec; 70(6):475-84. PubMed ID: 19049703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of Contrast-Induced Nephropathy by Central Venous Pressure-Guided Fluid Administration in Chronic Kidney Disease and Congestive Heart Failure Patients.
    Qian G; Fu Z; Guo J; Cao F; Chen Y
    JACC Cardiovasc Interv; 2016 Jan; 9(1):89-96. PubMed ID: 26685074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Alprostadil on the Prevention of Contrast-Induced Nephropathy: A Meta-Analysis of 36 Randomized Controlled Trials.
    Xie J; Jiang M; Lin Y; Deng H; Li L
    Angiology; 2019 Aug; 70(7):594-612. PubMed ID: 30669852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remedial hydration reduces the incidence of contrast-induced nephropathy and short-term adverse events in patients with ST-segment elevation myocardial infarction: a single-center, randomized trial.
    Luo Y; Wang X; Ye Z; Lai Y; Yao Y; Li J; Liu X
    Intern Med; 2014; 53(20):2265-72. PubMed ID: 25318787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Multidimensional Nursing Intervention for Pain on Pain Levels in Patients with Lower Extremity Arteriosclerosis Obliterans.
    Yang M; Zhao S; He Y
    Altern Ther Health Med; 2022 Jul; 28(5):38-43. PubMed ID: 35648692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.